The Science and Art of COVID Vaccines

Both the Pfizer and Moderna COVID vaccines have been authorized for use in the United States, and more are on the way.  This presentation will describe how these new authorized vaccines differ from vaccines that have been used in the past and will discuss how limited doses of vaccines will initially be provided.  Additional discussion will focus on other COVID vaccines in the pipeline, and their potential advantages and disadvantages.

Joel Ernst trained in Internal Medicine, Infectious Diseases, and in Hematology and Oncology at the University of California, San Francisco.  He joined the faculty at UCSF where he established a research program in host-pathogen interactions and immunity, and cared for patients with infectious diseases, including the earliest AIDS patients, at San Francisco General Hospital.  He was recruited to the NYU School of Medicine in 2003, where he was Director of the Division of Infectious Diseases and Immunology as well as Director of the Graduate Program in Immunology and Inflammation, and Professor of Medicine, Pathology, and Microbiology.  In 2018, he was recruited to UCSF where he is Professor of Medicine and Chief of the Division of Experimental Medicine.